Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Silo Pharma ( (SILO) ) has shared an announcement.
On May 16, 2025, Silo Pharma completed a public offering of shares and warrants, raising approximately $1.56 million in net proceeds. The company plans to use the funds for working capital and general corporate purposes, which may impact its operations and market positioning by providing financial resources for its developmental projects.
More about Silo Pharma
Silo Pharma Inc. is a developmental stage biopharmaceutical company focused on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system diseases. The company’s portfolio includes innovative programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Silo’s research is conducted in collaboration with leading universities and laboratories.
Average Trading Volume: 254,004
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.75M
Learn more about SILO stock on TipRanks’ Stock Analysis page.